American Tungsten & Antimony LtdASX: AT4

Dr Ivy Estabrooke Appointed Director and Appendix 3X

· Issued by American Tungsten & Antimony Ltd via ASX

Filed with ASX · · 5 pages · English

Summary by 6ix AI

American Tungsten & Antimony Ltd has announced the appointment of Dr Ivy Estabrooke as an Independent Non-Executive Director, effective immediately. Dr Estabrooke brings extensive experience in US Government procurement and critical minerals, which will enhance the company's capabilities in these areas. The filing includes an Initial Director’s Interest Notice detailing Dr Estabrooke's interests in the company, confirming her independence as a director. This strategic appointment is seen as crucial for advancing the company's US-focused mine-to-metal strategy.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

19 October 2026 AMERICAN TUNGSTEN & ANTIMONY LTD ACN 168 269 752 A 15B/531 Hay Street, Subiaco WA 6008 Australia P +61 (08) 6256 4403 | E [email protected] | W www.ataa.com Page 1 of 3 AT4 APPOINTS US DEFENCE SUPPLY CHAIN AND CRITICAL MINERALS EXECUTIVE TO BOARD Dr Ivy Estabrooke brings US...

American Tungsten & Antimony Ltd on 6ix

Story so far

Earlier from American Tungsten & Antimony

Later from American Tungsten & Antimony

All American Tungsten & Antimony news releases